Patent ID: 8354370

Claim:
A method of administering a therapeutically useful amount of a biological composition or compositions to an organ, tissue, or subject, comprising: (a) isolating a biological composition or compositions from culture media in which an isolated population of bone marrow-derived self-renewing colony forming somatic cells (CF-SC) had been grown; and, (b) administering said biological composition or compositions to said organ, tissue, or subject, wherein said CF-SC do not have multipotent differentiation capacity, wherein said CF-SC have a normal karyotype, wherein said CF-SC are non-immortalized, wherein said CF-SC express CD13, CD44, CD49c, CD90, HLA Class-1 and β (beta) 2-Microglobulin, and wherein said CF-SC do not express CD10, CD34, CD45, CD62L, or CD106.